The launch of the Caregiver AI Prize Competition by the Administration for Community Living under the U.S. Department of Health and Human Services signals a policy shift that matters beyond a single challenge. Federal leaders are no longer treating caregiving technology as a consumer convenience category. The competition frames AI as a potential layer of national caregiving infrastructure, with explicit expectations around responsible use and harm prevention. That framing raises the bar for what counts as a viable solution in the home.

The newly signed federal funding bill marks a pivotal moment for U.S. healthcare policy by pairing short-term budget stability with long-term shifts in care delivery and drug pricing regulation. Signed into law by President Trump on February 4, the legislation extends key telehealth flexibilities, prolongs the Acute Hospital Care at Home waiver, and implements the most substantive pharmacy benefit manager (PBM) reforms to date.

A growing body of evidence suggests that photon-counting computed tomography (PCCT) may soon eclipse conventional CT as the standard imaging modality in lung cancer management. In a newly published prospective study of 200 adults, photon-counting CT was found to significantly reduce radiation exposure and contrast-related risks while delivering higher image quality and superior detection of malignant features compared to traditional CT systems. The findings, published in Radiology by the Radiological Society of North America (RSNA), offer both compelling clinical implications and new operational considerations for imaging leaders, oncologists, and hospital CFOs alike.